What To Know: In a Thursday press conference, Trump told reporters that popular fat-loss drugs like Eli Lilly's Mounjaro and Novo Nordisk's (NYSE:NVO) Ozempic will see price reductions. The comments sent shares of GLP-1 drugmakers lower in after-hours trading on Thursday.
GLP-1 medications are used to treat Type 2 diabetes and obesity. Tirzepatide is the active ingredient in Eli Lilly's Mounjaro and Zepbound, while semaglutide is the active ingredient in Novo Nordisk's Ozempic and Wegovy.
How To Buy Eli Lilly Stock
By now you're likely curious about how to participate in the market for Eli Lilly – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.
See Also: Marsh & McLennan Analysts Slash Their Forecasts Following Q3 Earnings
LLY Price Action: At the time of writing, Eli Lilly shares are trading 2.42% lower at $799.53, according to data from Benzinga Pro.
Image via Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
